Marvin L. White - 04 Mar 2022 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role
President and CEO, Director
Signature
/s/ SoYoung Kwon, attorney-in-fact
Issuer symbol
APVO
Transactions as of
04 Mar 2022
Net transactions value
$0
Form type
4
Filing time
04 Mar 2022, 17:13:08 UTC
Previous filing
01 Feb 2022
Next filing
31 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APVO Stock Option (right to buy) Award $0 +28,750 $0.000000 28,750 04 Mar 2022 Common Stock 28,750 $5.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in three approximately equal annual installments beginning on March 3, 2023.